Company intelligence / Profile preview
Eyekare Kilitch
- Ownership
- Private
- Employees
- ~566
- Development stage
- Other
Overview
Eyekare Kilitch markets a broad portfolio of ophthalmic drugs and devices including preservative-free eye drops, gels, and injection kits, leveraging patented delivery systems to address unmet needs in dry eye, glaucoma, and retinal disease. The products are manufactured in USFDA and UKMHRA-compliant facilities; several packaging and delivery innovations are first-in-India and have approval for use in major markets.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small moleculeBiologicDevice
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Eyekare Kilitch.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eyekare Kilitch.